The healthcare industry is witnessing significant advancements in immunotherapy and plasma-derived treatments, driving strong growth in the subcutaneous immunoglobulins sector. Increasing prevalence of primary immunodeficiency diseases, neurological disorders, and autoimmune conditions has accelerated demand for convenient and effective immunoglobulin therapies. Home-based treatment preferences...